478163-35-8 Usage
Uses
Used in Pharmaceutical Industry:
(2-Fluoro-6-methylphenyl)methanol, (6-Fluoro-o-tolyl)methanol is used as intermediates for the synthesis of pharmaceuticals due to their unique chemical properties and reactivity, which make them valuable building blocks for creating more complex organic molecules.
Used in Agrochemical Industry:
(2-Fluoro-6-methylphenyl)methanol, (6-Fluoro-o-tolyl)methanol is used as intermediates for the synthesis of agrochemicals, leveraging their structural similarities to other aromatic alcohols and their potential as precursors to biologically active compounds.
Used in Organic Chemistry Research:
(2-Fluoro-6-methylphenyl)methanol, (6-Fluoro-o-tolyl)methanol is used as reagents in various organic reactions, taking advantage of their unique chemical properties to explore new synthetic pathways and develop novel compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 478163-35-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,8,1,6 and 3 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 478163-35:
(8*4)+(7*7)+(6*8)+(5*1)+(4*6)+(3*3)+(2*3)+(1*5)=178
178 % 10 = 8
So 478163-35-8 is a valid CAS Registry Number.
478163-35-8Relevant articles and documents
Compounds for the treatment of metabolic disorders
-
Page/Page column 93-95, (2016/03/12)
Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2
-
Page/Page column 51, (2008/06/13)
This invention provides chemical inhibitors of the activity of various phospholipase enzymes, particularly cytosolic phospholipase A2 enzymes (cPLA2), more particularly including inhibitors of cytosolic phospholipase A2 alpha enzymes (cPLAα). In some embodiments, the inhibitors have the Formula I: wherein the constituent variables are as defined herein.
Compounds for the treatment of metabolic disorders
-
, (2008/06/13)
Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.